U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06903715) titled 'A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)' on March 25.
Brief Summary: Researchers designed belzutifan, the study medicine, to treat certain kinds of cancer.
The goal of this study is to learn what happens to belzutifan in a healthy person's body over time when taken, by mouth, as a tablet. Researchers will learn what happens when belzutifan is taken alone and when it is taken after several days of treatment with phenytoin.
Study Start Date: March 26
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Belzutifan
Oral administration
DRUG: Phen...